Should pharmacoeconomic studies always be published? Newsletter Article 13 February 2013 Pages: 2 - 2
Standardisation or reinvention of health economic guidelines? Newsletter Article 13 February 2013 Pages: 6 - 6
Projects show the way to successful disease management Newsletter Article 13 February 2013 Pages: 6 - 6
HIV triple therapy ‘exceedingly expensive’ in sub-Saharan Africa Newsletter Article 13 February 2013 Pages: 7 - 7
All patients with ALS should be entitled to riluzole therapy Newsletter Article 13 February 2013 Pages: 7 - 7
Antibacterial prescribing influenced by patients’ expectations Newsletter Article 13 February 2013 Pages: 8 - 8
Chemotherapy alone adequate for non-Hodgkin’s lymphoma Newsletter Article 13 February 2013 Pages: 10 - 10
Celiprolol more effective than atenolol in reducing coronary risk Newsletter Article 13 February 2013 Pages: 10 - 10
Merck-Medco alliance links demand and disease management Newsletter Article 13 February 2013 Pages: 12 - 12